DK0842668T3 - Fremgangsmåde til ex-corpore-behandling af humane blodceller - Google Patents
Fremgangsmåde til ex-corpore-behandling af humane blodcellerInfo
- Publication number
- DK0842668T3 DK0842668T3 DK96118377T DK96118377T DK0842668T3 DK 0842668 T3 DK0842668 T3 DK 0842668T3 DK 96118377 T DK96118377 T DK 96118377T DK 96118377 T DK96118377 T DK 96118377T DK 0842668 T3 DK0842668 T3 DK 0842668T3
- Authority
- DK
- Denmark
- Prior art keywords
- corpore
- blood cells
- radionuclides
- conjugated
- cells
- Prior art date
Links
- 210000000601 blood cell Anatomy 0.000 abstract 2
- 210000001185 bone marrow Anatomy 0.000 abstract 2
- 229940051022 radioimmunoconjugate Drugs 0.000 abstract 2
- 210000004881 tumor cell Anatomy 0.000 abstract 2
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 238000011534 incubation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 238000010926 purge Methods 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 210000000130 stem cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- External Artificial Organs (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96118377A EP0842668B1 (en) | 1996-11-15 | 1996-11-15 | Ex-corpore method for treating human blood cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0842668T3 true DK0842668T3 (da) | 2003-01-06 |
Family
ID=8223402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96118377T DK0842668T3 (da) | 1996-11-15 | 1996-11-15 | Fremgangsmåde til ex-corpore-behandling af humane blodceller |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20020119488A1 (da) |
| EP (1) | EP0842668B1 (da) |
| JP (1) | JP2001508765A (da) |
| AT (1) | ATE223237T1 (da) |
| CA (1) | CA2270391C (da) |
| DE (1) | DE69623482T2 (da) |
| DK (1) | DK0842668T3 (da) |
| ES (1) | ES2183904T3 (da) |
| PT (1) | PT842668E (da) |
| WO (1) | WO1998020909A2 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2422291C (en) * | 2000-09-15 | 2011-03-08 | Sloan-Kettering Institute For Cancer Research | Targeted alpha particle therapy using actinium-225 conjugates |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2122641B (en) * | 1982-06-07 | 1986-08-06 | Otto A Gansow | Metal chelate conjugated monoclonal antibodies where in the metal is an emitter |
| CA2034484C (en) * | 1989-06-19 | 2000-08-15 | Maurits W. Geerlings | Radioimmunotherapy using .alpha.-particles emission |
| LU87684A1 (de) * | 1990-02-23 | 1991-10-08 | Euratom | Verfahren zur erzeugung von aktinium-225 und wismut-213 |
| CA2100709C (en) * | 1992-07-27 | 2004-03-16 | Maurits W. Geerlings | Method and means for site directed therapy |
| US6107457A (en) * | 1995-02-16 | 2000-08-22 | Board Of Regents, The University Of Texas System | Bcr-Abl directed compositions and uses for inhibiting Philadelphia chromosome stimulated cell growth |
-
1996
- 1996-11-15 DK DK96118377T patent/DK0842668T3/da active
- 1996-11-15 DE DE69623482T patent/DE69623482T2/de not_active Expired - Lifetime
- 1996-11-15 EP EP96118377A patent/EP0842668B1/en not_active Expired - Lifetime
- 1996-11-15 PT PT96118377T patent/PT842668E/pt unknown
- 1996-11-15 ES ES96118377T patent/ES2183904T3/es not_active Expired - Lifetime
- 1996-11-15 AT AT96118377T patent/ATE223237T1/de active
-
1997
- 1997-11-10 WO PCT/EP1997/006221 patent/WO1998020909A2/en not_active Ceased
- 1997-11-10 JP JP52214998A patent/JP2001508765A/ja not_active Ceased
- 1997-11-10 CA CA002270391A patent/CA2270391C/en not_active Expired - Fee Related
- 1997-11-10 US US09/297,557 patent/US20020119488A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998020909A2 (en) | 1998-05-22 |
| CA2270391C (en) | 2007-01-09 |
| WO1998020909A3 (en) | 2000-06-29 |
| EP0842668B1 (en) | 2002-09-04 |
| DE69623482D1 (de) | 2002-10-10 |
| ES2183904T3 (es) | 2003-04-01 |
| EP0842668A1 (en) | 1998-05-20 |
| PT842668E (pt) | 2003-01-31 |
| US20020119488A1 (en) | 2002-08-29 |
| ATE223237T1 (de) | 2002-09-15 |
| DE69623482T2 (de) | 2003-01-30 |
| JP2001508765A (ja) | 2001-07-03 |
| CA2270391A1 (en) | 1998-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2346644A1 (en) | Method for preventing xenograft transplant rejection using photodynamic therapy | |
| ATE358493T1 (de) | Menschliche mesenchymale stammzellen aus peripherem blut | |
| ATE394078T1 (de) | Eine resorbierbare röntgenopake markierung enthaltendes chirurgisches implantat | |
| ATE454166T1 (de) | Behandlung von patienten die eine knochenmarktransplantation oder eine transplantation peripherer blutstammzellen erhalten mit anti-cd20 antikörpern | |
| PT1059929E (pt) | Células do estroma isoladas para uso no tratamento de doenças do sistema nervoso central | |
| DE69626205D1 (de) | Terminal-sterilisierte osteogene vorrichtungen und ihre herstellung | |
| MY113490A (en) | Modified anti-icam-1 antibodies and their use in the treatment of inflammation | |
| DK0603920T3 (da) | Fremgangsmåde til behandling af knoglevæv og tilsvarende implanterbare biologiske materialer | |
| AU5035998A (en) | Enhancement of xenograft tolerance and porcine cytokines therefor | |
| DK1400252T3 (da) | Fremgangsmåde og sammensætninger til heling og reparation af ledbrusk | |
| EP0368902A4 (en) | Method for eradicating infectious contaminants in tissues | |
| ATE300310T1 (de) | Verfahren zur steigerung von hematopoietischen zellen | |
| DE69330899D1 (de) | Verwendung von Bismuth-213 Konjugate zur Behandlung von Mikrometastasen | |
| ATE428928T1 (de) | Verfahren zur einführung von heterologischen zellen in fische | |
| IL144523A0 (en) | Method and compositions for healing and repair of articular cartilage | |
| DE60035697D1 (de) | Screening nach verbindungen, die tgf-beta abhängige zellsignale modifizieren können | |
| PT842668E (pt) | Metodo ex-corpore de tratamento de celulas humanas sanguineas | |
| EP2219733B1 (en) | Method of treatment of dermis and uses of said dermis | |
| ES2056099T3 (es) | Metodo para tratar material para implantacion, e implante. | |
| ATE474590T1 (de) | Kombination von immunsuppressiven substanzen zur behandlung oder vorbeugung von transplantat abstossungen | |
| Claas et al. | Influence of ultraviolet radiation treatment on the survival of heterotopic skin grafts in the mouse | |
| WO1998008956A3 (en) | Use of a mutated macrolide binding protein for the prevention of gvhd | |
| ES2072331T3 (es) | Procedimiento para la descontaminacion de cultivos celulares que contienen micoplasmas. | |
| RU2210997C2 (ru) | Способ стимуляции остеоиндукции в эксперименте | |
| EP1156292A3 (en) | Device for treatment of biological waste |